Myomo

Focus: Myomo develops neurorobotic arm braces and orthoses to restore movement and function in patients with arm weakness from neurological conditions. The company operates in the medical device segment within neurology, serving a specialized market for post-stroke and traumatic brain injury rehabilitation.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Myomo

AI assessmentNot Hiring

No open roles listed right now. Follow Myomo to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

MyoPro Motion-G

Traumatic Brain Injury

Growth

Lead neurorobotic device candidate addressing TBI-related arm weakness with early clinical validation.

myomo e100 neurorobotic elbow brace

Stroke (CVA)

Help build intelligence for Myomo

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pioneering position in neurorobotics and functional orthosis technology, a nascent but high-impact field addressing unmet needs in stroke and TBI recovery
Portfolio focused on neurology with 6 active clinical programs targeting stroke and traumatic brain injury, expanding addressable market
Medical device model allows for faster commercialization pathways compared to traditional small-molecule or biologic drug development

Watch Out For

No current job openings listed (0 active positions), suggesting minimal near-term hiring or potential organizational contraction
Early-stage pipeline with only 1 Phase 1 program and remainder at pre-clinical/non-clinical phases, indicating limited clinical validation and revenue visibility
Critical financial data unavailable (revenue, cash position, R&D spend), making stability and growth trajectory assessment impossible

Generated by Claude from Myomo's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Core product platform targeting post-stroke arm paralysis, the company's primary indication focus.

Pipeline & Clinical Trials

myomo e100 neurorobotic elbow brace

CVA (Cerebrovascular Accident)

N/A

Clinical Trials (1)

NCT00396708Wearable Robotic Functional Assistance for Stroke Rehabilitation

N/A

Myoelectric Elbow-Wrist-Hand Orthosis

Stroke

N/A

Clinical Trials (1)

NCT04900896Outcome Measures Study on an Adult Myoelectric Elbow-Wrist-Hand Orthosis

N/A

Myoelectric Elbow-Wrist-Hand Orthosis

Stroke

N/A

Clinical Trials (1)

NCT05575674Retrospective Study on Myoelectric Elbow-Wrist-Hand Orthosis User Outcomes

N/A

Myoelectric Elbow-Wrist-Hand orthosis

Cerebrovascular Accidents

N/A

Clinical Trials (1)

NCT02544672Function Benefits of a Myoelectric Elbow-Wrist-Hand Orthosis

N/A

MyoPro Motion-G

Traumatic Brain Injury

N/A

Clinical Trials (1)

NCT03215771Myoelectric Upper Limb Orthosis Use by Persons With TBI and Stroke

N/A

myomo e100

Stroke

Phase 1

Clinical Trials (1)

NCT00820638Myomo e100 NeuroRobotic System Home Safety Study

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 6 clinical trials

Top TAs: Neurology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Neurology

4 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 3 crawl cycles